Compare MNTS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNTS | ELUT |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 35.6M |
| IPO Year | 2019 | 2020 |
| Metric | MNTS | ELUT |
|---|---|---|
| Price | $1.82 | $0.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 746.7K | 74.8K |
| Earning Date | 11-23-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | N/A | ★ N/A |
| Revenue | $1,110,000.00 | ★ $12,293,000.00 |
| Revenue This Year | $660.36 | N/A |
| Revenue Next Year | $42.18 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.44 | $0.50 |
| 52 Week High | $22.20 | $1.39 |
| Indicator | MNTS | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 30.53 | 50.10 |
| Support Level | $1.56 | $0.73 |
| Resistance Level | $2.30 | $0.87 |
| Average True Range (ATR) | 0.25 | 0.07 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 34.46 | 51.37 |
Momentus Inc is a U.S.-based commercial space company engaged in providing satellites, satellite buses, and in-space infrastructure services. The company offers space transportation, hosted payload, and in-orbit servicing solutions, including last-mile satellite delivery, refueling, inspection, maintenance, and debris removal. It also develops satellite technologies such as solar arrays and propulsion systems, and provides production and operation of small satellites for government, defense, and commercial customers.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.